Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis
Rev. Assoc. Med. Bras. (1992, Impr.); 68 (2), 2022
Results: 3
Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates
Braz. j. microbiol; 48 (1), 2017
Abstract Vulvovaginal candidiasis (VVC) is an infection of the genital mucosa caused by different species of the genus Candida. Considering the lack of data on this topic in the south of Brazil, this study aimed to assess the prevalence of Candida spp. in the cervical-vaginal mucosa of patients treated a...
Candida/efectos de los fármacos, Candidiasis Vulvovaginal/epidemiología, Candidiasis Vulvovaginal/microbiología, Antifúngicos/farmacología, Brasil/epidemiología, Candida/clasificación, Candida/aislamiento & purificación, Farmacorresistencia Fúngica, Infecciones por VIH, Pruebas de Sensibilidad Microbiana, Prevalencia
Susceptibility and molecular characterization of Candida species from patients with vulvovaginitis
Braz. j. microbiol; 47 (2), 2016
Abstract Vulvovaginal candidiasis affects women of reproductive age, which represents approximately 15–25% of vaginitis cases. The present study aimed to isolate and characterize yeast from the patients irrespective of the presentation of clinical symptoms. The isolates were subjected to in vitro s...
Antifúngicos/farmacología, Candida/efectos de los fármacos, Candidiasis Vulvovaginal/microbiología, Candida/clasificación, Candida/genética, Candida/aislamiento & purificación, Farmacorresistencia Fúngica, Fluconazol/farmacología, Pruebas de Sensibilidad Microbiana, Pacientes/estadística & datos numéricos